Côd QR

Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer

Background: Dyspnea is a severe symptom of terminal-stage interstitial pneumonia (IP). We commonly use continuous morphine or midazolam for terminal refractory dyspnea. Objective: We aimed to determine whether there is a difference in the use of continuous morphine and midazolam for terminal dyspnea...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Hiroko Okabayashi, Hideya Kitamura, Satoshi Ikeda, Akimasa Sekine, Tsuneyuki Oda, Tomohisa Baba, Eri Hagiwara, Takuro Sakagami, Takashi Ogura
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publishing 2021-06-01
Cyfres:Palliative Medicine Reports
Pynciau:
interstitial pneumonia
lung cancer
midazolam
morphine
palliative care
palliative sedatives
Mynediad Ar-lein:https://www.liebertpub.com/doi/full/10.1089/PMR.2021.0010
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg